NASDAQ: GTBP GT Biopharma, Inc. 8-K

GT Biopharma commits $3.8M to University of Minnesota phase 1 trial of GTB-5550 in solid tumors

Filed April 7, 2026 · Period ending April 3, 2026 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade GTBP commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 3, 2026 6:58 PM